AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bone Metabolism Assays - Global Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

November 20, 2019

DUBLIN--(BUSINESS WIRE)--Nov 20, 2019--

The “Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

This report provides an overview of Bone Metabolism Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products.

Scope

Reasons to Buy

Key Topics Covered

1 Table of Contents

2 Introduction

2.1 Bone Metabolism Assays Overview

3 Products under Development

3.1 Bone Metabolism Assays - Pipeline Products by Stage of Development

3.2 Bone Metabolism Assays - Pipeline Products by Segment

3.3 Bone Metabolism Assays - Pipeline Products by Territory

3.4 Bone Metabolism Assays - Pipeline Products by Regulatory Path

3.5 Bone Metabolism Assays - Pipeline Products by Estimated Approval Date

4 Bone Metabolism Assays - Pipeline Products under Development by Companies

4.1 Bone Metabolism Assays Companies - Pipeline Products by Stage of Development

4.2 Bone Metabolism Assays - Pipeline Products by Stage of Development

5 Bone Metabolism Assays Companies and Product Overview

5.1 Alere Inc

5.2 AMS Diagnostics LLC

5.3 Beckman Coulter Inc

5.4 Carolina Liquid Chemistries Corp

5.5 DiaSorin SpA

5.6 Immunodiagnostic Systems Holdings plc

5.7 Novartis AG

5.8 OJ-Bio Ltd (Inactive)

5.9 Shenzhen Mindray Bio-Medical Electronics Co Ltd

5.10 Siemens Healthineers AG

5.11 Tosoh Bioscience Inc

6 Bone Metabolism Assays - Recent Developments

6.1 Mar 07, 2019: Mindray signs patient safety movement’s open data pledge & becomes 90th company to join to improve patient safety

6.2 Dec 04, 2018: Mindray international exchange program on hematology: linking medical expertise across borders

For more information about this report visit https://www.researchandmarkets.com/r/fet3gh

View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005611/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: PHARMACEUTICAL SCIENCE HEALTH RESEARCH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/20/2019 10:12 AM/DISC: 11/20/2019 10:12 AM

http://www.businesswire.com/news/home/20191120005611/en